This year we celebrate not only the 50th anniversary of the Medicines Act 1968, aspects of which I have been discussing during the last few weeks, but also the 400th […]
Jeff Aronson’s Words
Jeffrey Aronson: When I use a word . . . The Medicines Act 1968 and Compendia
Last week I noted that section 96(6) of the Medicines Act 1968 required marketing authorization holders to publish information about their medicinal products in data sheets, whose form and contents […]
Jeffrey Aronson: When I use a word . . . The Medicines Act 1968, Data Sheets, and Summaries of Product Characteristics
Last week, during my exploration of the Medicines Act 1968, I discussed its provisions in relation to the promotion of sales of medicinal products, and the idea of a data […]
Jeffrey Aronson: When I use a word . . . The Medicines Act 1968 and advertising medicinal products
Continuing my exploration, during Clinical Pharmacology Month, of the Medicines Act 1968, I turn to Part VI, “Promotion of Sales of Medicinal Products” (§§92–97); i.e. advertising. The IndoEuropean root WER, […]
Jeffrey Aronson: When I use a word . . . Licensing, authorization, and the Medicines Act 1968
As I discussed last week, Clinical Pharmacology Month, currently in progress, is a good occasion during which to reflect on the 50th anniversary of the Medicines Act 1968 and its […]
Jeffrey Aronson: When I use a word . . . Medicine, medicines, and the Medicines Act 1968
As I pointed out last week, the IndoEuropean root MED, to measure or take appropriate measures, has given rise to a large number of English words, among them “medicine” and […]
Jeffrey Aronson: When I use a word . . . Must and should
Sometimes “must” and “should” get confused. The IndoEuropean root MED and its o-grade form MOD meant to measure or take appropriate measures, and hence to ponder, judge, or prescribe. Hence […]
Jeffrey Aronson: When I use a word . . . Liquorice and glycyrrhetinic acid
As I described two weeks ago, phenylbutazone was the first marketed compound to be later classified as a non-steroidal anti-inflammatory drug. However, the first drug to be so described seems […]
Jeffrey Aronson: When I use a word . . . Non-steroidal anti-inflammatory drugs—origin of the term
As I discussed last week, non-steroidal anti-inflammatory drugs (NSAIDs) form a heterogeneous group of compounds, primarily defined by being anti-inflammatory and secondarily by not being steroids. The word “steroid”, which […]
Jeffrey Aronson: When I use a word . . . Non-drugs
As I discussed last week, definitions should preferably not include negations. Some terms that denote drug classes break this rule. Non-vitamin K antagonist oral anticoagulants (NOACs), for example, form a […]